<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">8812164</journal-id>
<journal-id journal-id-type="pubmed-jr-id">1373</journal-id>
<journal-id journal-id-type="nlm-ta">J Autoimmun</journal-id>
<journal-id journal-id-type="iso-abbrev">J. Autoimmun.</journal-id>
<journal-title-group>
<journal-title>Journal of autoimmunity</journal-title>
</journal-title-group>
<issn pub-type="ppub">0896-8411</issn>
<issn pub-type="epub">1095-9157</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">29310926</article-id>
<article-id pub-id-type="pmc">5902429</article-id>
<article-id pub-id-type="doi">10.1016/j.jaut.2017.12.008</article-id>
<article-id pub-id-type="manuscript">NIHMS932806</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Identification of non-HLA genes associated with development of islet autoimmunity and type 1 diabetes in the prospective TEDDY cohort</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Sharma</surname>
<given-names>Ashok</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Liu</surname>
<given-names>Xiang</given-names>
</name>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Hadley</surname>
<given-names>David</given-names>
</name>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Hagopian</surname>
<given-names>William</given-names>
</name>
<xref ref-type="aff" rid="A4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Chen</surname>
<given-names>Wei-Min</given-names>
</name>
<xref ref-type="aff" rid="A5">5</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Onengut-Gumuscu</surname>
<given-names>Suna</given-names>
</name>
<xref ref-type="aff" rid="A5">5</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Törn</surname>
<given-names>Carina</given-names>
</name>
<xref ref-type="aff" rid="A6">6</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Steck</surname>
<given-names>Andrea K.</given-names>
</name>
<xref ref-type="aff" rid="A7">7</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Frohnert</surname>
<given-names>Brigitte I.</given-names>
</name>
<xref ref-type="aff" rid="A7">7</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Rewers</surname>
<given-names>Marian</given-names>
</name>
<xref ref-type="aff" rid="A7">7</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ziegler</surname>
<given-names>Anette-G.</given-names>
</name>
<xref ref-type="aff" rid="A8">8</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Lernmark</surname>
<given-names>Åke</given-names>
</name>
<xref ref-type="aff" rid="A6">6</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Toppari</surname>
<given-names>Jorma</given-names>
</name>
<xref ref-type="aff" rid="A9">9</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Krischer</surname>
<given-names>Jeffrey P.</given-names>
</name>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Akolkar</surname>
<given-names>Beena</given-names>
</name>
<xref ref-type="aff" rid="A10">10</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Rich</surname>
<given-names>Stephen S.</given-names>
</name>
<xref ref-type="aff" rid="A5">5</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>She</surname>
<given-names>Jin-Xiong</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<collab>for the TEDDY Study Group</collab>
<xref ref-type="author-notes" rid="FN2">*</xref>
</contrib>
</contrib-group>
<aff id="A1">
<label>1</label>Center for Biotechnology and Genomic Medicine, Medical College of Georgia, Augusta University, Augusta, GA, USA</aff>
<aff id="A2">
<label>2</label>Health Informatics Institute, Morsani College of Medicine, University of South Florida, Tampa, FL, USA</aff>
<aff id="A3">
<label>3</label>Division of Population Health Sciences and Education, St George’s University of London, London, United Kingdom</aff>
<aff id="A4">
<label>4</label>Pacific Northwest Research Institute, Seattle, WA, USA</aff>
<aff id="A5">
<label>5</label>Center for Public Health Genomics, University of Virginia, Charlottesville, VA, USA</aff>
<aff id="A6">
<label>6</label>Department of Clinical Sciences, Lund University/CRC, Malmö, Sweden</aff>
<aff id="A7">
<label>7</label>Barbara Davis Center for Childhood Diabetes, University of Colorado, Denver, Aurora, CO, USA</aff>
<aff id="A8">
<label>8</label>Institute of Diabetes Research, Helmholtz Zentrum München, and Klinikum rechts der Isar, Technische Universität München, and Forschergruppe Diabetes e.V., Munich-Neuherberg, Germany</aff>
<aff id="A9">
<label>9</label>Department of Pediatrics, Turku University Hospital, Turku, Finland</aff>
<aff id="A10">
<label>10</label>Department of Physiology, Institute of Biomedicine, University of Turku, Turku, Finland</aff>
<aff id="A11">
<label>11</label>National Institutes of Diabetes and Digestive and Kidney Disorders, National Institutes of Health, Bethesda, MD, USA</aff>
<author-notes>
<corresp id="FN1"><bold>Correspondence author:</bold> Dr. Jin-Xiong She, Center for Biotechnology and Genomic Medicine, Medical College of Georgia, Augusta University, 1120 15th Street, Augusta, GA 30912. <email>jshe@augusta.edu</email>, Phone: 706-721-3410, Fax: 706-721-3688</corresp>
<fn id="FN2">
<label>*</label>
<p id="P1">A complete list of the TEDDY Study Group can be found in the <xref ref-type="supplementary-material" rid="SD5">Supplementary Appendix online</xref>.</p>
</fn>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>6</day>
<month>1</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="epub">
<day>05</day>
<month>1</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="ppub">
<month>5</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>01</day>
<month>5</month>
<year>2019</year>
</pub-date>
<volume>89</volume>
<fpage>90</fpage>
<lpage>100</lpage>
<!--elocation-id from pubmed: 10.1016/j.jaut.2017.12.008-->
<abstract>
<p id="P2">Traditional linkage analysis and genome-wide association studies have identified HLA and a number of non-HLA genes as genetic factors for islet autoimmunity (IA) and type 1 diabetes (T1D). However, the relative risk associated with previously identified non-HLA genes is usually very small as measured in cases/controls from mixed populations. Genetic associations for IA and T1D may be more accurately assessed in prospective cohorts. In this study, 5,806 subjects from the TEDDY (The Environmental Determinants of Diabetes in the Young) study, an international prospective cohort study, were genotyped for 176,586 SNPs on the ImmunoChip. Cox proportional hazards analyses were performed to discover the SNPs associated with the risk for IA, T1D, or both. Three regions were associated with the risk of developing any persistent confirmed islet autoantibody: one known region near <italic>SH2B3</italic> (HR= 1.35, p = 3.58 ×10<sup>−7</sup>) with Bonferroni-corrected significance and another known region near <italic>PTPN22</italic> (HR= 1.46, p = 2.17×10<sup>−6</sup>) and one novel region near <italic>PPIL2</italic> (HR = 2.47, p = 9.64×10<sup>−7</sup>) with suggestive evidence (p&lt;10<sup>−5</sup>). Two known regions (<italic>PTPN22:</italic> p = 2.25×10<sup>−6</sup>, <italic>INS</italic>; p = 1.32×10<sup>−7</sup>) and one novel region (<italic>PXK/PDHB:</italic> p = 8.99×10<sup>−6</sup>) were associated with the risk for multiple islet autoantibodies. First appearing islet autoantibodies differ with respect to association. Two regions (<italic>INS</italic>: p=5.67×10<sup>−6</sup> and <italic>TTC34/PRDM16</italic>: 6.45×10<sup>−6</sup>) were associated if the fist appearing autoantibody was IAA and one region (<italic>RBFOX1</italic>: p=8.02×10<sup>−6</sup>) was associated if the first appearing autoantibody was GADA. The analysis of T1D identified one region already known to be associated with T1D (<italic>INS</italic>: p = 3.13×10<sup>−7</sup>) and three novel regions (<italic>RNASET2, PLEKHA1,</italic> and <italic>PPIL2</italic>; 5.42×10<sup>−6</sup> &gt; p &gt; 2.31×10<sup>−6</sup>). These results suggest that a number of low frequency variants influence the risk of developing IA and/or T1D and these variants can be identified by large prospective cohort studies using a survival analysis approach.</p>
</abstract>
<kwd-group>
<kwd>TEDDY Study</kwd>
<kwd>autoimmune disorder</kwd>
<kwd>gene mapping</kwd>
<kwd>susceptibility</kwd>
<kwd>type 1 diabetes</kwd>
</kwd-group>
</article-meta>
</front>
</article>
</pmc-articleset>